Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 6.70 (1.67%)
Spread: 0.20 (0.049%)
Open: 408.90
High: 409.60
Low: 404.30
Prev. Close: 401.00
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Capital Markets Day

28 Sep 2021 07:00

RNS Number : 1305N
Rentokil Initial PLC
28 September 2021
 

28 September 2021

 

RENTOKIL INITIAL PLC (RTO)

 

Notice of Capital Markets Day - 'Hygiene: The New Pest Control',

revised growth targets and changes to Category and Regional structure

 

 

Rentokil Initial plc will be holding a Capital Markets Day for investors and analysts at 12.00pm today at The Great Hall, Chartered Accountants' Hall, One Moorgate Place, London EC2R 6EA.

 

The event will include a series of presentations by senior executive and operational management to provide greater insight into the Group's Hygiene business. These sessions will include presentations on our core washroom business, growth opportunities outside of the washroom (including Air Care, Dental Hygiene, Medical, Specialist Hygiene, Wellbeing, Plants and Scenting) expansion of our geographic footprint, M&A and our financial model to compound growth. The event will start with a number of sessions on our Pest Control business, focusing on digital technology, PestConnect, innovation and M&A. Attendees will also be able to view displays on innovation, digital capability and ESG during the event.

 

The Company will not give an update on current trading today, but will be announcing revised medium-term growth targets as well as changes to its Category and Regional structure from 1 January 2022. No changes are being made to the Company's capital allocation model or dividend policy.

 

Medium-term growth targets

 

The Company will announce the following changes to its medium-term targets:

 

Previous Targets

New Targets

 

Organic Revenue growth:

 

Group: 3% - 4%

Pest Control: 4% - 6%

Hygiene: 2% - 3%

Workwear: N/A

 

 

Organic Revenue growth:

 

Group: 4% - 5% (ex. Disinfection)

Pest Control: 4.5% - 6.5%

Hygiene & Wellbeing: 4% - 6% (ex. Disinfection)

Workwear: 3% - 4%

 

Ongoing Revenue growth: 5% to 8%

 

Ongoing Revenue growth: 6% to 9%

(of which M&A 2% to 5%)

Ongoing Operating Profit growth: c.10%

Ongoing Operating Profit growth: 10%+

Free Cash Flow: c.90% cash conversion

Free Cash Flow: c.90% cash conversion

 

Category structure

 

In response to the COVID-19 pandemic and the increasing importance of hygiene and wellbeing services, we are expanding our Hygiene category with effect from 1 January 2022. The enlarged category, called Hygiene & Wellbeing, will comprise our current Hygiene operations together with our Ambius, Dental Hygiene and Cleanroom services operations, previously part of our Protect & Enhance category. In addition, the Group's UK Property Care business (also formerly in Protect & Enhance) will join the Pest Control category. France Workwear will become the Group's third business category.

 

Regional structure

 

The number of regions within the Group will remain unchanged. The Rest of World businesses, which were previously included within the UK & Rest of World region, will be transferred to other regions to better reflect their geographic locations. This includes: Poland and the Nordics, which will be transferred to Europe; our Caribbean operations, which will move to Latin America; and our businesses in MENAT, which will move to the Asia region and which will be renamed Asia & MENAT. Our Sub-Saharan Africa operations will continue to be reported within the UK. There will be no major changes to our North America region, with the exception of Puerto Rico transferring to Latin America. The Pacific region will remain unchanged, comprising Australia, New Zealand and Fiji. Consequently, the five regions will be named North America, Europe, UK & Sub-Saharan Africa, Asia & MENAT and Pacific. This new reporting structure will take effect from 1 January 2022.

 

Rentokil Initial will publish its Q3 Trading Statement at 7.00am on 21 October 2021.

Today's presentations will be web cast live and will be available on a replay facility for the foreseeable future at www.rentokil-initial.com. If you would like to follow our live webcast, online registration is required and will be available from 7.00am this morning on https://rentokilinitial.connectid.cloud with log in for the event from 11:30am. For access links and information please visit rentokil-initial.com.

 

Rentokil Initial is one of the largest business services companies in the world, operating in 87 countries. The Company offers route-based services including Pest Control, Hygiene and Wellbeing, and Workwear through over 45,000 employees around the world. For more information, visit www.rentokil-initial.com.

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKNXASAFEFA
Date   Source Headline
29th Jul 20217:00 amRNSInterim Results
8th Jul 20217:00 amRNSNotice of termination of guarantee
11th Jun 20211:50 pmRNSNotice of Early Redemption
12th May 20216:03 pmRNSResult of AGM
22nd Apr 20217:00 amRNSQ1 Trading Update
7th Apr 20212:01 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
1st Apr 202110:23 amRNSBlock listing Interim Review
1st Apr 202110:16 amRNSChange of Registered Office
31st Mar 20214:00 pmRNSDirector/PDMR Shareholding
31st Mar 20211:16 pmRNSTotal Voting Rights
31st Mar 202110:33 amRNSAnnual Financial Report
30th Mar 20216:23 pmRNSDirector Declaration
24th Mar 20215:55 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSAdditional Listing
4th Mar 20217:05 amRNSDirectorate Change
4th Mar 20217:00 amRNSFinal Results
17th Feb 20215:45 pmRNSDirector Declaration
8th Jan 20217:00 amRNSQ4 2020 Acquisitions and Trading Update
27th Nov 20202:25 pmBUSEarly Repurchase(s)
27th Nov 20202:22 pmBUSEarly Repurchase(s)
24th Nov 20205:25 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Tender Offer for Notes due 2021
12th Nov 20209:02 amRNSTender Offer for Notes due 2021
22nd Oct 20207:00 amRNSQ3 Trading Update
8th Oct 20207:00 amRNSSuccessful EUR600m 8-year bond transaction priced
1st Oct 20209:00 amRNSBlock listing Interim Review
28th Aug 20203:40 pmRNSDirector/PDMR Shareholding
7th Aug 20205:24 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSInterim Results
6th Jul 20207:00 amRNSDirectorate Change
21st May 202011:00 amRNSDirector/PDMR Shareholding
13th May 20205:15 pmRNSResult of AGM
7th May 20204:45 pmRNSDirector/PDMR Shareholding
27th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202011:59 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSQ1 Trading Update
14th Apr 20205:26 pmRNSHolding(s) in Company
9th Apr 20204:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
1st Apr 20205:33 pmRNSConfirmation of Non-Executive Director Appointment
1st Apr 20209:24 amRNSBlock listing Interim Review
31st Mar 20202:18 pmRNSTotal Voting Rights
30th Mar 202012:37 pmRNSRedemption of 4.5% debenture stock
30th Mar 202012:24 pmRNSRedemption of 5% debenture stock
27th Mar 202011:00 amRNSHolding(s) in Company
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202011:29 amRNSAnnual Financial Report
25th Mar 20207:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.